Anixa biosciences announces presentation on its ovarian cancer car-t clinical trial at the international gynecologic cancer society 2024 annual meeting

San jose, calif. , july 29, 2024 /prnewswire/ -- anixa biosciences, inc. ("anixa" or the "company") (nasdaq: anix), a biotechnology company focused on the treatment and prevention of cancer, today announced a presentation on its ovarian cancer car-t therapy clinical trial at the international gynecologic cancer society (igcs) 2024 annual global meeting being held october 16-18, 2024, in dublin, ireland.
CAR Ratings Summary
CAR Quant Ranking